Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis

Byung Soh Min, Jin Soo Kim, Nam Kyu Kim, Joon Seok Lim, Kang Young Lee, Chang Hwan Cho, Seung Kook Sohn

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: The purpose of this study is to review the clinical outcomes of patients who received extended lymph node dissection for radiologically diagnosed extramesenteric lymph node metastasis. Patients and Methods: The authors reviewed clinical characteristics, short-term operative outcomes, and long-term oncologic outcomes of 151 patients who had received total mesorectal excision plus extended lymph node dissection for the treatment of radiologically diagnosed extramesenteric lymph node metastasis. Results: The positive predictive value of the radiologic diagnosis of extramesenteric lymph node metastasis was 86.4% for lateral nodes and 40.0% for para-aortic nodes. It showed improvement over time. Perioperative mortality occurred in 3 patients (2.0%) and morbidity in 31 patients (20.5%). Pathologic examinations revealed metastatic para-aortic lymph nodes in 43 patients (PA) and metastatic lateral pelvic nodes in 36 patients (LP), while in 21 patients, metastasis was found in both (LP + PA). Both cancer-specific survival (CSS) and disease-free survival (DFS) were significantly different according to the extent of node metastasis (CSS: P < .001; DFS: P < .001) and univariate and multivariate analyses for prognostic factors revealed that the lymph node status as to location was the only factor. Conclusion: Patients with extramesenteric lymph node metastasis may be a distinct subgroup with poor prognosis. Extended lymph node dissection may have a role for those patients. However, the optimal treatment strategy remains inconclusive, for which further clinical research is necessary.

Original languageEnglish
Pages (from-to)3271-3278
Number of pages8
JournalAnnals of surgical oncology
Volume16
Issue number12
DOIs
Publication statusPublished - 2009 Dec 1

Fingerprint

Rectal Neoplasms
Lymph Node Excision
Lymph Nodes
Neoplasm Metastasis
Disease-Free Survival
Survival
Neoplasms
Multivariate Analysis
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Min, Byung Soh ; Kim, Jin Soo ; Kim, Nam Kyu ; Lim, Joon Seok ; Lee, Kang Young ; Cho, Chang Hwan ; Sohn, Seung Kook. / Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. In: Annals of surgical oncology. 2009 ; Vol. 16, No. 12. pp. 3271-3278.
@article{ffff1741890d4586ae2430c2d103762d,
title = "Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis",
abstract = "Background: The purpose of this study is to review the clinical outcomes of patients who received extended lymph node dissection for radiologically diagnosed extramesenteric lymph node metastasis. Patients and Methods: The authors reviewed clinical characteristics, short-term operative outcomes, and long-term oncologic outcomes of 151 patients who had received total mesorectal excision plus extended lymph node dissection for the treatment of radiologically diagnosed extramesenteric lymph node metastasis. Results: The positive predictive value of the radiologic diagnosis of extramesenteric lymph node metastasis was 86.4{\%} for lateral nodes and 40.0{\%} for para-aortic nodes. It showed improvement over time. Perioperative mortality occurred in 3 patients (2.0{\%}) and morbidity in 31 patients (20.5{\%}). Pathologic examinations revealed metastatic para-aortic lymph nodes in 43 patients (PA) and metastatic lateral pelvic nodes in 36 patients (LP), while in 21 patients, metastasis was found in both (LP + PA). Both cancer-specific survival (CSS) and disease-free survival (DFS) were significantly different according to the extent of node metastasis (CSS: P < .001; DFS: P < .001) and univariate and multivariate analyses for prognostic factors revealed that the lymph node status as to location was the only factor. Conclusion: Patients with extramesenteric lymph node metastasis may be a distinct subgroup with poor prognosis. Extended lymph node dissection may have a role for those patients. However, the optimal treatment strategy remains inconclusive, for which further clinical research is necessary.",
author = "Min, {Byung Soh} and Kim, {Jin Soo} and Kim, {Nam Kyu} and Lim, {Joon Seok} and Lee, {Kang Young} and Cho, {Chang Hwan} and Sohn, {Seung Kook}",
year = "2009",
month = "12",
day = "1",
doi = "10.1245/s10434-009-0692-1",
language = "English",
volume = "16",
pages = "3271--3278",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "12",

}

Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. / Min, Byung Soh; Kim, Jin Soo; Kim, Nam Kyu; Lim, Joon Seok; Lee, Kang Young; Cho, Chang Hwan; Sohn, Seung Kook.

In: Annals of surgical oncology, Vol. 16, No. 12, 01.12.2009, p. 3271-3278.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis

AU - Min, Byung Soh

AU - Kim, Jin Soo

AU - Kim, Nam Kyu

AU - Lim, Joon Seok

AU - Lee, Kang Young

AU - Cho, Chang Hwan

AU - Sohn, Seung Kook

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Background: The purpose of this study is to review the clinical outcomes of patients who received extended lymph node dissection for radiologically diagnosed extramesenteric lymph node metastasis. Patients and Methods: The authors reviewed clinical characteristics, short-term operative outcomes, and long-term oncologic outcomes of 151 patients who had received total mesorectal excision plus extended lymph node dissection for the treatment of radiologically diagnosed extramesenteric lymph node metastasis. Results: The positive predictive value of the radiologic diagnosis of extramesenteric lymph node metastasis was 86.4% for lateral nodes and 40.0% for para-aortic nodes. It showed improvement over time. Perioperative mortality occurred in 3 patients (2.0%) and morbidity in 31 patients (20.5%). Pathologic examinations revealed metastatic para-aortic lymph nodes in 43 patients (PA) and metastatic lateral pelvic nodes in 36 patients (LP), while in 21 patients, metastasis was found in both (LP + PA). Both cancer-specific survival (CSS) and disease-free survival (DFS) were significantly different according to the extent of node metastasis (CSS: P < .001; DFS: P < .001) and univariate and multivariate analyses for prognostic factors revealed that the lymph node status as to location was the only factor. Conclusion: Patients with extramesenteric lymph node metastasis may be a distinct subgroup with poor prognosis. Extended lymph node dissection may have a role for those patients. However, the optimal treatment strategy remains inconclusive, for which further clinical research is necessary.

AB - Background: The purpose of this study is to review the clinical outcomes of patients who received extended lymph node dissection for radiologically diagnosed extramesenteric lymph node metastasis. Patients and Methods: The authors reviewed clinical characteristics, short-term operative outcomes, and long-term oncologic outcomes of 151 patients who had received total mesorectal excision plus extended lymph node dissection for the treatment of radiologically diagnosed extramesenteric lymph node metastasis. Results: The positive predictive value of the radiologic diagnosis of extramesenteric lymph node metastasis was 86.4% for lateral nodes and 40.0% for para-aortic nodes. It showed improvement over time. Perioperative mortality occurred in 3 patients (2.0%) and morbidity in 31 patients (20.5%). Pathologic examinations revealed metastatic para-aortic lymph nodes in 43 patients (PA) and metastatic lateral pelvic nodes in 36 patients (LP), while in 21 patients, metastasis was found in both (LP + PA). Both cancer-specific survival (CSS) and disease-free survival (DFS) were significantly different according to the extent of node metastasis (CSS: P < .001; DFS: P < .001) and univariate and multivariate analyses for prognostic factors revealed that the lymph node status as to location was the only factor. Conclusion: Patients with extramesenteric lymph node metastasis may be a distinct subgroup with poor prognosis. Extended lymph node dissection may have a role for those patients. However, the optimal treatment strategy remains inconclusive, for which further clinical research is necessary.

UR - http://www.scopus.com/inward/record.url?scp=71549157125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71549157125&partnerID=8YFLogxK

U2 - 10.1245/s10434-009-0692-1

DO - 10.1245/s10434-009-0692-1

M3 - Article

C2 - 19763693

AN - SCOPUS:71549157125

VL - 16

SP - 3271

EP - 3278

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 12

ER -